Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Objectives To compare the therapeutic effects of locoregional deep hyperthermia combined with intravesical chemotherapy with those of intravesical chemotherapy alone in patients with intermediate-/high-risk non-muscle invasive bladder cancer (NMIBC). To evaluate the impact of thermal dose in hyperth...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef8eb434c29f47f7921177420b1a3c34 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ef8eb434c29f47f7921177420b1a3c34 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ef8eb434c29f47f7921177420b1a3c342021-11-17T14:21:55ZLoco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer0265-67361464-515710.1080/02656736.2021.2001582https://doaj.org/article/ef8eb434c29f47f7921177420b1a3c342021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/02656736.2021.2001582https://doaj.org/toc/0265-6736https://doaj.org/toc/1464-5157Objectives To compare the therapeutic effects of locoregional deep hyperthermia combined with intravesical chemotherapy with those of intravesical chemotherapy alone in patients with intermediate-/high-risk non-muscle invasive bladder cancer (NMIBC). To evaluate the impact of thermal dose in hyperthermia treatment. Methods We analyzed data retrieved from the medical records of patients with intermediate-/high-risk NMIBC treated with intravesical mitomycin (IM group) or locoregional deep hyperthermia combined with intravesical mitomycin (CHT group) at a single tertiary care hospital between May 2016 and June 2019. The primary and secondary endpoints were the recurrence-free survival rate and progression-free survival rate, respectively. Thermal dose was evaluated and adverse events were also recorded. Results In total, 43 patients (CHT: 18 patients, IM: 25 patients) were enrolled. The median follow-up durations were 14 and 23 months, respectively. The recurrence rate at 12 months was significantly lower in the CHT group than in the IM group (11.1% vs. 44%, p = .048); this trend persisted at 24 months (CHT: 11.1%, IM: 48%; p = .027). The recurrence-free survival was also significantly higher in the CHT group than in the IM group (p = .028). No tumor recurrence was noted in patients who received a thermal dose of ≥4 CEM43. All adverse events were well tolerated, and there was no treatment-related mortality. Conclusions Intravesical chemotherapy combined with locoregional deep hyperthermia for intermediate-/high-risk papillary NMIBC can significantly decrease the recurrence rate relative to that observed after intravesical chemotherapy alone.Yu-Ching WenLiang-Ming LeeYung-Wei LinSyuan-Hao SyuKe-Hsun LinYen-Chun FanHsin-Lun LeeBenjamin Chung Howe LaiHung-Jen ShihTaylor & Francis Grouparticlemitomycinhyperthermiabladder cancerrecurrencethermal doseMedical technologyR855-855.5ENInternational Journal of Hyperthermia, Vol 38, Iss 1, Pp 1627-1632 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
mitomycin hyperthermia bladder cancer recurrence thermal dose Medical technology R855-855.5 |
spellingShingle |
mitomycin hyperthermia bladder cancer recurrence thermal dose Medical technology R855-855.5 Yu-Ching Wen Liang-Ming Lee Yung-Wei Lin Syuan-Hao Syu Ke-Hsun Lin Yen-Chun Fan Hsin-Lun Lee Benjamin Chung Howe Lai Hung-Jen Shih Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
description |
Objectives To compare the therapeutic effects of locoregional deep hyperthermia combined with intravesical chemotherapy with those of intravesical chemotherapy alone in patients with intermediate-/high-risk non-muscle invasive bladder cancer (NMIBC). To evaluate the impact of thermal dose in hyperthermia treatment. Methods We analyzed data retrieved from the medical records of patients with intermediate-/high-risk NMIBC treated with intravesical mitomycin (IM group) or locoregional deep hyperthermia combined with intravesical mitomycin (CHT group) at a single tertiary care hospital between May 2016 and June 2019. The primary and secondary endpoints were the recurrence-free survival rate and progression-free survival rate, respectively. Thermal dose was evaluated and adverse events were also recorded. Results In total, 43 patients (CHT: 18 patients, IM: 25 patients) were enrolled. The median follow-up durations were 14 and 23 months, respectively. The recurrence rate at 12 months was significantly lower in the CHT group than in the IM group (11.1% vs. 44%, p = .048); this trend persisted at 24 months (CHT: 11.1%, IM: 48%; p = .027). The recurrence-free survival was also significantly higher in the CHT group than in the IM group (p = .028). No tumor recurrence was noted in patients who received a thermal dose of ≥4 CEM43. All adverse events were well tolerated, and there was no treatment-related mortality. Conclusions Intravesical chemotherapy combined with locoregional deep hyperthermia for intermediate-/high-risk papillary NMIBC can significantly decrease the recurrence rate relative to that observed after intravesical chemotherapy alone. |
format |
article |
author |
Yu-Ching Wen Liang-Ming Lee Yung-Wei Lin Syuan-Hao Syu Ke-Hsun Lin Yen-Chun Fan Hsin-Lun Lee Benjamin Chung Howe Lai Hung-Jen Shih |
author_facet |
Yu-Ching Wen Liang-Ming Lee Yung-Wei Lin Syuan-Hao Syu Ke-Hsun Lin Yen-Chun Fan Hsin-Lun Lee Benjamin Chung Howe Lai Hung-Jen Shih |
author_sort |
Yu-Ching Wen |
title |
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
title_short |
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
title_full |
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
title_fullStr |
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
title_full_unstemmed |
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
title_sort |
loco-regional deep hyperthermia combined with intravesical mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer |
publisher |
Taylor & Francis Group |
publishDate |
2021 |
url |
https://doaj.org/article/ef8eb434c29f47f7921177420b1a3c34 |
work_keys_str_mv |
AT yuchingwen locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT liangminglee locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT yungweilin locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT syuanhaosyu locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT kehsunlin locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT yenchunfan locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT hsinlunlee locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT benjaminchunghowelai locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer AT hungjenshih locoregionaldeephyperthermiacombinedwithintravesicalmitomycininstillationreducestherecurrenceofnonmuscleinvasivepapillarybladdercancer |
_version_ |
1718425519663349760 |